APA
Iqbal J., Verheye S., Abizaid A., Ormiston J., de Vries T., Morrison L., Toyloy S., Fitzgerald P., Windecker S. & Serruys P. W. (20170615). DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial. : EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
Chicago
Iqbal Javaid, Verheye Stefan, Abizaid Alexandre, Ormiston John, de Vries Ton, Morrison Lynn, Toyloy Sara, Fitzgerald Peter, Windecker Stephan and Serruys Patrick W. 20170615. DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial. : EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
Harvard
Iqbal J., Verheye S., Abizaid A., Ormiston J., de Vries T., Morrison L., Toyloy S., Fitzgerald P., Windecker S. and Serruys P. W. (20170615). DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial. : EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
MLA
Iqbal Javaid, Verheye Stefan, Abizaid Alexandre, Ormiston John, de Vries Ton, Morrison Lynn, Toyloy Sara, Fitzgerald Peter, Windecker Stephan and Serruys Patrick W. DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial. : EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 20170615.